Developed with trade secret scientific methodologies and validated by independent clinical testing, BioBlend Technology™ emerges as one of the most powerful innovations in skincare and hair restoration.
Harnessing the Power of Great Science
Bioblend Technology™ is a sophisticated blend of high-powered growth factors and exosomes, sourced from a proprietary blend of multiple cell sources known to play a vital role in facial rejuvenation and hair restoration.
Validated by Science, Proven in Clinical Studies
INVO products are not just innovative, they’re effective. Each formula undergoes rigorous clinical testing to validate its safety and efficacy. Our studies suggest significant improvements in overall facial rejuvenation and hair restoration, delivering genuine, lasting results.
A New Approach to Aesthetic Solutions
Independently Tested, Precisely Characterized
BioBlend Technology™ has undergone seven rounds of third-party laboratory testing and analysis to characterize its composition and safety profile.
- Growth factor, protein, and peptide quantification — High-Performance Liquid Chromatography-Mass Spectrometry, Proteomics Laboratory, Clarkson University (October 2024)
- Protein composition mapping — Antibody Microarray, RayBiotech Life (October 2024)
- Exosome characterization — Nanoparticle Analysis, System Biosciences (October 2024)
- Structural imaging — Electron Microscopy, Electron Microscopy Core Facility, UCLA (October 2024)
- Pathway analysis — Protein Pathway Analysis, Clarkson University Protein Core Facility (October 2024)
- Cellular activity assessment — Gene Expression and Cellular Senescence Analysis, Bio Discovery Labs (August 2024)
- Cellular safety screening — Bio Discovery Labs (September 2024)
Together, this testing quantified over 1,200 growth factors, proteins, and peptides, and over 361 billion exosomes per mL in BioBlend Technology™.
These evaluations characterize the composition and cellular safety profile of BioBlend Technology™. They are laboratory analyses, not clinical efficacy trials.
Case Study: Collagen and Elastin Response
Following formulation, INVO collaborated with an independent dermatopathologist to evaluate skin changes in a single patient in her mid-to-late 40s. The patient applied Rejuvenating Complex twice daily for five weeks. Skin biopsies were taken at baseline and after the five-week period and evaluated histologically.
The findings suggest that BioBlend Technology™ may support collagen production while reducing fragmented elastin fibers associated with solar elastosis. Papillary dermal thickness also increased — a finding consistent with improved dermal architecture.
This is a single-patient case study, not a controlled clinical trial. Individual results vary.
Join the INVO Community
INVO is more than just a brand; it's a community of individuals passionate about unlocking their full potential. Join us on this journey towards radiant, healthy skin and hair. Experience the transformative power of regenerative aesthetics with INVO Aesthetics.
